Johnson & Johnson pauses U.S. Varipulse cases to investigate neurovascular events. The FDA-approved device integrates PFA ...

In that single-arm study, the rate of primary adverse events within 7 days of ablation was 2.9%, with the most common ...

Forget taking an electrocardiogram from your wrist; now you can take one from your finger. The Circular Ring Gen 2, which was ...

Looking back, Kokomo resident Mike Beatty knew he had something as a teenager, but he couldn’t put a name to it. Whenever he’d overexert himself, he’d feel “different,” but it would go away with rest.

Smart ring brand Circular is laying down claims at CES 2025 that its brand new Ring 2 will run, ahem, rings around the ...

About 200,000 Louisiana residents are living with a heart condition called atrial fibrillation but there is a new treatment ...

Esophageal squamous cell carcinoma (ESCC) is a severe health threat, being a predominant subtype of esophageal cancer and ...

The temporary pause will allow the company to investigate four neurovascular events seen in an external validation study.

Despite the pause, the company clarified that the suspension does not impact commercial activity outside the US.

The Circular Ring Slim didn't live up to our expectations, but the next generation could fix all of its flaws. Here's what we ...

Chuck's cycling journey living with AFib, from diagnosis to catheter ablation to recovery, read about living and riding with ...